Survival analysis in breast cancer using proteomic data from four independent datasets
Abstract Breast cancer clinical treatment selection is based on the immunohistochemical determination of four protein biomarkers: ESR1, PGR, HER2, and MKI67. Our aim was to correlate immunohistochemical results to proteome-level technologies in measuring the expression of these markers. We also aime...
Saved in:
Main Authors: | , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/98b06f65bfd74ceea979747b3df6d25b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|